Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 38

Sort by

Sort Order Select

Journal Articles

Tumor Circulating Plasma Cells Detected By Flow Cytometric Single Platform Method Correlate with Clinical Response to Therapy and Unfavorable Patients' Characteristics

Blood (2019) 134 (Supplement_1): 4357.

https://doi.org/10.1182/blood-2019-122657

Published: 2019

Journal Articles

Utilizing Multiparametric Flow Cytometry to Identify Patients with Primary Plasma Cell Leukemia at Diagnosis

Blood (2019) 134 (Supplement_1): 4334.

https://doi.org/10.1182/blood-2019-126777

Published: 2019

Journal Articles

Next Generation Flow Cytometry Provides a Standardized, Highly Sensitive and Informative Method for the Analysis of Circulating Plasma Cells in Newly Diagnosed Multiple Myeloma: A Single Center Study in 182 Patients

Evangelos Terpos, MD PhD, Ioannis V. Kostopoulos, Aristea-Maria Papanota, MD, Konstantinos Papadimitriou, BSc, Panagiotis Malandrakis, MD, Paraskevi Micheli, BSc, Ioannis Ntanasis-Stathopoulos, MD, Despina Fotiou, MD, Andreas Metousis, BSc, Nikolaos Kanellias, MD, Magdalini Migkou, MD, Evangelos Eleutherakis-Papaiakovou, MD, Maria Gavriatopoulou, MD, Eftathios Kastritis, Ourania E. Tsitsilonis, MD PhD, Meletios A. Dimopoulos, MD

Blood (2019) 134 (Supplement_1): 4338.

https://doi.org/10.1182/blood-2019-127989

Published: 2019

Journal Articles

Impact of Osseous and Non-Osseous Extramedullary Disease in Multiple Myeloma: Clinical Characteristics and Outcomes in a Latin American Population

Cesar Vargas-Serafin, MD, Aldo A Acosta-Medina, MS, Juan Rangel-Patiño, MD, Daniela Perez-Samano, MD, Deborah M. Martinez-Banos, Christianne Bourlon, MD

Blood (2019) 134 (Supplement_1): 5527.

https://doi.org/10.1182/blood-2019-128791

Published: 2019

Journal Articles

Impact of Treatment on B-Cell Regeneration By Next Generation Flow Cytometry in Patients with Multiple Myeloma

Robéria Pontes, MSc, Juan Flores-Montero, Luzalba Sanoja-Flores, Noemi Puig, MD PhD, Roberto José Pessoa Magalhães, MD, Alba Corral Mateos, Anna Beatriz Salgado, Angelo Maiolino, MD, Maria-Victoria Mateos, MD PhD, Bruno Paiva, MD PhD, Elaine Sobral da Costa, PhD, Jacques JM van Dongen, Alberto Orfao, MD PhD

Blood (2018) 132 (Supplement 1): 4491.

https://doi.org/10.1182/blood-2018-99-117162

Published: 2018

Journal Articles

Altered Epigenetic Maturation in Early Erythroid Cells from Diamond Blackfan Anemia Patients Treated with Transfusions, Corticosteroids, or in Remission

Jason E. Farrar, MD, Jessica Kang, BS, Nancy Seidel, Jens Lichtenberg, Evangelia Atsidaftos, MA, MPH, Jeffrey M Lipton, MD PhD, Adrianna Vlachos, MD, David M. Bodine, PhD

Blood (2018) 132 (Supplement 1): 752.

https://doi.org/10.1182/blood-2018-99-116994

Published: 2018

Journal Articles

Straightforward Transition to Bay 81-8973 Prophylaxis in Patients with Hemophilia A: Prospective Real-World Data from the Taurus Non-Interventional Study Show That Number of Infusions per Week Is Maintained or Reduced

Michael Wang, Beng Fuh, MD, Philip Maes, MD, Maria Eva Mingot-Castellano, PhD MD, Rubén Berrueco, MD, Phu-Quoc Le, MD PhD, Stephan Rauchensteiner, Cristina Santoro, MD PhD

Blood (2018) 132 (Supplement 1): 5045.

https://doi.org/10.1182/blood-2018-99-116622

Published: 2018

Journal Articles

Emicizumab Prophylaxis Provides Flexible and Effective Bleed Control in Children with Hemophilia Α with Inhibitors: Results from the HAVEN 2 Study

Guy Young, Ri Liesner, Robert F. Sidonio, Jr., Johannes Oldenburg, Victor Jimenez-Yuste, Johnny Mahlangu, Rebecca Kruse-Jarres, Michael Wang, Tiffany Chang, Marianne Uguen, Michelle Doral, Christophe Schmitt, Gallia G. Levy, Midori Shima, MD PhD, Maria Elisa Mancuso

Blood (2018) 132 (Supplement 1): 632.

https://doi.org/10.1182/blood-2018-99-118153

Published: 2018

Journal Articles

Real-World Data of Immune Tolerance Induction Using rFVIIIFc in Subjects With Severe Hemophilia A With Inhibitors at High Risk for ITI Failure

Manuel Carcao, Amy Shapiro, Nina Hwang, Steven Pipe, Sanjay Ahuja, Kenneth Lieuw, MD PhD, Janice Staber, Haowei Linda Sun, Hilda Ding, Michael Wang, Macgregor Steele, Elisa Tsao, Jing Feng, Zahra Al-Khateeb, Jennifer Dumont, Nisha Jain

Blood (2018) 132 (Supplement 1): 2500.

https://doi.org/10.1182/blood-2018-99-110467

Published: 2018

Journal Articles

Determinants of Prophylaxis Regimen Choice for Patients with Hemophilia Α Switching to Bay 81-8973: Real World Findings from the Taurus Non-Interventional Study

Beng Fuh, MD, Cristina Santoro, MD PhD, Philip Maes, MD, Maria Eva Mingot-Castellano, PhD MD, Rubén Berrueco, MD, Phu-Quoc Le, MD PhD, Stephan Rauchensteiner, Michael Wang

Blood (2018) 132 (Supplement 1): 5023.

https://doi.org/10.1182/blood-2018-99-116737

Published: 2018

Journal Articles

Prognostic Relevance of Clonal Circulating Plasma Cells Detected By Multiparameter Flow Cytometry in Patients with Newly Diagnosed Multiple Myeloma Treated with Novel Agents: Comparative Investigation with the Revised International Staging System

Yoshiaki Abe, Kentaro Narita, MD, Hiroki Kobayashi, MD, Akihiro Kitadate, MD, Masami Takeuchi, MD, Kosei Matsue, MD PhD

Blood (2017) 130 (Supplement 1): 4354.

https://doi.org/10.1182/blood.V130.Suppl_1.4354.4354

Published: 2017

Journal Articles

Plasma Cell Leukemia (PCL): Clinical Characteristics, Outcomes, and the Impact of Circulating Plasma Cells (CPC) Percentage — A Single Center Experience

Noa G. Holtzman, MD, Olga Goloubeva, PhD MSc, Zeba Singh, MBBS, Sameer Sawhney, MD, Ying Zou, MD PhD, Jean Yared, MD, Nancy M. Hardy, MD, Aaron P. Rapoport, MD, Mehmet H. Kocoglu, MD, Ashraf Z. Badros, MD

Blood (2017) 130 (Supplement 1): 3035.

https://doi.org/10.1182/blood.V130.Suppl_1.3035.3035

Published: 2017

Journal Articles

Simultaneous Monitoring of Drug Responses on Distinct Hematopoietic Cell Populations Allow Assessment of Direct and Indirect Cytotoxic Effects of Targeted Therapies

Muntasir M Majumder, MSc, MPharm, Aino Maija Leppä, BSc, Caroline A Heckman, PhD

Blood (2016) 128 (22): 3515.

https://doi.org/10.1182/blood.V128.22.3515.3515

Published: 2016

Journal Articles

A Novel Approach to the Medical Student Hematology Curriculum

Erik A Levinsohn, BA, Michael P DiGiovanna, MD PhD, John Encandela, PhD, Peter A Takizawa, PhD, Janet P Hafler, EdD, Alfred I Lee, MD PhD

Blood (2016) 128 (22): 3537.

https://doi.org/10.1182/blood.V128.22.3537.3537

Published: 2016

Journal Articles

Genomic Discovery, Prognosis, and Target Therapy Development

Jude Fitzgibbon, PhD

Blood (2016) 128 (22): SCI-6.

https://doi.org/10.1182/blood.V128.22.SCI-6.SCI-6

Published: 2016

Journal Articles

Early Steps of Follicular Lymphoma Pathogenesis

Bertrand Nadel, PhD

Blood (2016) 128 (22): SCI-5.

https://doi.org/10.1182/blood.V128.22.SCI-5.SCI-5

Published: 2016

Journal Articles

Next Generation Flow (NGF): A High Sensitive Technique to Detect Circulating Peripheral Blood (PB) Clonal Plasma Cells (cPC) in Patients with Newly Diagnosed of Plasma Cell Neoplasms (PCN)

*Luzalba Sanoja-Flores, M.Sc., *Bruno Paiva, PhD, Juan A Flores-Montero, MD, Noemi Puig, MD PhD, Leire Burgos, Omar García, PhD, Felipe Prosper, MD, Juana Merino, MDPhD, Maria Belen Vidriales, MD PhD, Maria-Victoria Mateos, Ramon Garcia, MD, Luis Palomera, MDPhD, Rafael Rios, María Consuelo Cañizo, MD PhD, Brian G M Durie, Jacques J.M. van Dongen, Jesus San Miguel, MDPhD, Alberto Orfao, MD PhD

Blood (2015) 126 (23): 4180.

https://doi.org/10.1182/blood.V126.23.4180.4180

Published: 2015

Journal Articles

Clinical Significance of Circulating Plasma Cells in Myeloma: Multiparameter Flow Cytometric Analysis

Manabu Fujisawa, MD, Yasuhito Suehara, MD, Kota Fukumoto, MD, Kentaro Narita, MD, Yoshiaki Usui, MD, Masami Takeuchi, MD, Kosei Matsue, MDPhD, Hiroyuki Takamatsu, MD PhD

Blood (2015) 126 (23): 5352.

https://doi.org/10.1182/blood.V126.23.5352.5352

Published: 2015

Journal Articles

Circulating Plasma Cells By Routine Complete Blood Count Identify Patients With Similar Outcome As Plasma Cell Leukemia

Rupin A Shah, M.B.B.S, Satyajit Mohite, M.B.B.S., Veerabhadran Baladandayuthapani, Ph.D., Sheeba K. Thomas, M.D., Donna M. Weber, M.D., Michael Wang, MD, Raymond Alexanian, M.D., Muzaffar H Qazilbash, MD, Uday R Popat, MD, Richard E Champlin, MD, Nina Shah, MD, Qaiser Bashir, MD, Simrit Parmar, MD, Yago Nieto, MD, PhD, Sairah Ahmed, MD, Robert Z. Orlowski, M.D., Ph.D., Jatin J. Shah, M.D.

Blood (2013) 122 (21): 5356.

https://doi.org/10.1182/blood.V122.21.5356.5356

Published: 2013

Journal Articles

Prospective, Open-label clinical Trial of Bivalirudin in Children with Venous Thromboembolism

Sarah H. O'Brien, MD, MSc, Donald Yee, MD, Jessica Lira, Neil A Goldenberg, MD, PhD, Guy Young, MD

Blood (2012) 120 (21): 1165.

https://doi.org/10.1182/blood.V120.21.1165.1165

Published: 2012

NARROW

Tumor Circulating Plasma Cells Detected By Flow Cytometric Single Platform Method Correlate with Clinical Response to Therapy and Unfavorable Patients' Characteristics

Utilizing Multiparametric Flow Cytometry to Identify Patients with Primary Plasma Cell Leukemia at Diagnosis

Next Generation Flow Cytometry Provides a Standardized, Highly Sensitive and Informative Method for the Analysis of Circulating Plasma Cells in Newly Diagnosed Multiple Myeloma: A Single Center Study in 182 Patients

Impact of Osseous and Non-Osseous Extramedullary Disease in Multiple Myeloma: Clinical Characteristics and Outcomes in a Latin American Population

Impact of Treatment on B-Cell Regeneration By Next Generation Flow Cytometry in Patients with Multiple Myeloma

Altered Epigenetic Maturation in Early Erythroid Cells from Diamond Blackfan Anemia Patients Treated with Transfusions, Corticosteroids, or in Remission

Straightforward Transition to Bay 81-8973 Prophylaxis in Patients with Hemophilia A: Prospective Real-World Data from the Taurus Non-Interventional Study Show That Number of Infusions per Week Is Maintained or Reduced

Emicizumab Prophylaxis Provides Flexible and Effective Bleed Control in Children with Hemophilia Α with Inhibitors: Results from the HAVEN 2 Study

Real-World Data of Immune Tolerance Induction Using rFVIIIFc in Subjects With Severe Hemophilia A With Inhibitors at High Risk for ITI Failure

Determinants of Prophylaxis Regimen Choice for Patients with Hemophilia Α Switching to Bay 81-8973: Real World Findings from the Taurus Non-Interventional Study

Prognostic Relevance of Clonal Circulating Plasma Cells Detected By Multiparameter Flow Cytometry in Patients with Newly Diagnosed Multiple Myeloma Treated with Novel Agents: Comparative Investigation with the Revised International Staging System

Plasma Cell Leukemia (PCL): Clinical Characteristics, Outcomes, and the Impact of Circulating Plasma Cells (CPC) Percentage — A Single Center Experience

Simultaneous Monitoring of Drug Responses on Distinct Hematopoietic Cell Populations Allow Assessment of Direct and Indirect Cytotoxic Effects of Targeted Therapies

A Novel Approach to the Medical Student Hematology Curriculum

Genomic Discovery, Prognosis, and Target Therapy Development

Early Steps of Follicular Lymphoma Pathogenesis

Next Generation Flow (NGF): A High Sensitive Technique to Detect Circulating Peripheral Blood (PB) Clonal Plasma Cells (cPC) in Patients with Newly Diagnosed of Plasma Cell Neoplasms (PCN)

Clinical Significance of Circulating Plasma Cells in Myeloma: Multiparameter Flow Cytometric Analysis

Circulating Plasma Cells By Routine Complete Blood Count Identify Patients With Similar Outcome As Plasma Cell Leukemia

Prospective, Open-label clinical Trial of Bivalirudin in Children with Venous Thromboembolism

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only